114450 — Green LifeScience Co Balance Sheet
0.000.00%
- KR₩31bn
- KR₩23bn
- KR₩25bn
Annual balance sheet for Green LifeScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14,833 | 15,903 | 16,649 | 14,453 | 12,885 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,117 | 3,661 | 3,034 | 1,582 | 5,102 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 24,572 | 26,892 | 26,443 | 21,712 | 21,991 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 35,626 | 36,846 | 27,112 | 13,256 | 13,533 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 70,846 | 71,977 | 62,432 | 43,828 | 44,972 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,781 | 15,242 | 9,437 | 7,394 | 8,314 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 11,475 | 15,679 | 9,793 | 7,874 | 9,224 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 59,371 | 56,298 | 52,639 | 35,954 | 35,748 |
Total Liabilities & Shareholders' Equity | 70,846 | 71,977 | 62,432 | 43,828 | 44,972 |
Total Common Shares Outstanding |